Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-16T15:06:47.444Z Has data issue: false hasContentIssue false

Torulopsis glabrata infections in Singapore: a 4-year study

Published online by Cambridge University Press:  15 May 2009

Rowland J. S. Tan
Affiliation:
Department of Microbiology, Faculty of Medicine, University of Singapore, Sepoy Lines, Singapore 3, Republic of Singapore
Ek-Wang Lim
Affiliation:
Department of Microbiology, Faculty of Medicine, University of Singapore, Sepoy Lines, Singapore 3, Republic of Singapore
Hock-Kin Teo
Affiliation:
Department of Pathology, Singapore General Hospital, Ministry of Health, Outram Road, Singapore 3, Republic of Singapore
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

During the period 1971–4, Torulopsis glabrata formed 42% of yeasts isolated from 5677 clinical specimens from patients with cancers, diabetes mellitus, chronic renal failure, pregnancy or major surgical operations complicated by mycotic infections. The significance of T. glabrata in these patients is discussed.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1977

References

REFERENCES

Aisner, J., Sickles, E. A., Stephen, C., Schimpff, S. C., Young, V. M., Greene, W. H. & Wiernik, P. H. (1974). Torulopsis glabrata pneumonitis in patients with cancer. Report of 3 cases. Journal of the American Medical Association 230, 584.CrossRefGoogle Scholar
Bagdade, J., Nielson, K., Root, R. & Bulger, R. (1970). Host defence in diabetes mellitus: the feckless phagocyte during poor control and ketoacidosis. Clinical Research 18, 181.Google Scholar
Baker, R. D. (1960). Diabetes and mucormycosis. Diabetes 9, 143.CrossRefGoogle ScholarPubMed
Baker, R. D. (1962). Leukopenia and therapy in leukaemia as factors predisposing to fatal mycoses. American Journal of Clinical Pathology 37, 358.CrossRefGoogle ScholarPubMed
Black, R. A. & Fisher, C. V. (1937). Cryptococcic bronchopneumonia. American Journal of Diseases in Children 54, 81.Google Scholar
Bybee, J. D. & Rogers, D. E. (1964). The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. Journal of Laboratory and Clinical Medicine 64, 1.Google ScholarPubMed
Edebo, L. & Spetz, A. (1965). Urinary tract infection with Torulopsis glabrata treated by alkalization of urine. British Medical Journal ii, 983.CrossRefGoogle Scholar
Grimley, P. M., Wright, L. D. & Jennings, A. E. (1965). Torulopsis glabrata infection in man. American Journal of Clinical Pathology 43, 216.CrossRefGoogle ScholarPubMed
Guze, L. B. & Haley, L. D. (1958). Fungus infections of the urinary tract. Yale Journal of Biology and Medicine 30, 292.Google ScholarPubMed
Hutter, R. V. P. & Collins, H. S. (1962). The occurrence of opportunistic fungus infections in a cancer hospital. Laboratory Investigation 11, 1035.Google Scholar
Katz, D. & Pickard, R. E. (1967). Systemic Torulopsis glabrata infection causing shock, fever and coma. American Journal of Medicine 43, 151.CrossRefGoogle ScholarPubMed
Kauffman, C. A. & Tan, J. S. (1974). Torulopsis glabrata renal infection. American Journal of Medicine 57, 217.CrossRefGoogle ScholarPubMed
Kockova-Kratochvilova, A. (1973). Comparative taxonomy of the Genus Torulopsis Berlese. The Journal of General Microbiology 79, 239.CrossRefGoogle ScholarPubMed
Louria, D. B., Blevins, A., Armstrong, D., Burdick, R. & Lieberman, P. (1967). Fungemia caused by nonpathogenic yeasts. Archives of Internal Medicine 119, 247.CrossRefGoogle ScholarPubMed
Marks, M. I., Langston, C. & Eickhoff, T. C. (1970). Torulopsis glabrata – an opportunistic pathogen in man. New England Journal of Medicine 283, 1131.CrossRefGoogle ScholarPubMed
McGovern, J. J., Parrott, R. H., Emmons, C. W., Ross, S., Burke, F. G. & Rice, E. C. (1953). The effect of aureomycin and chloramphenicol on the fungal and bacterial flora of children. New England Journal of Medicine 248, 397.CrossRefGoogle ScholarPubMed
McVay, L. V. & Sprunt, D. H. (1951). A study of moniliasis in aureomycin therapy. Proceedings of the Society for experimental Biology and Medicine 78, 759.CrossRefGoogle ScholarPubMed
Melnick, S. & Smith, D. E. (1974). Candida tropicalis and Torulopsis glabrata fungemia in a patient treated with long term hyperalimentation. American Surgeon 40, 190.Google Scholar
Perille, P. E., Nolan, J. P. & Finch, S. C. (1962). Studies of the resistance to infection in diabetes mellitus: local exudative cellular response. Journal of Laboratory and Clinical Medicine 59, 1008.Google Scholar
Sharp, J. L. (1954). The growth of Candida albicans during antibiotic therapy. Lancet i, 390.CrossRefGoogle Scholar
Sheldon, W. H. & Bauer, H. (1962). The role of disposing factors in experimental fungus infections. Laboratory Investigation 11, 1184.Google Scholar
Silva-Hutner, M. & Cooper, B. H. (1974). Medically important yeasts. In Manual of Clinical Microbiology, 2nd ed.(ed. Lennette, E. H., Spaulding, E. H. and Truant, J. P.), p. 491. American Society for Microbiology, U.S.A.Google Scholar
Speller, D. C. E. (1974). Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine. Journal of clinical Pathology 27, 50.CrossRefGoogle ScholarPubMed
Stenderup, A. & Pederson, G. T. (1962). Yeasts of human origin. Acta pathologica et microbiologica scandinavica 54, 462.CrossRefGoogle ScholarPubMed
Torack, R. M. (1957). Fungus infections associated with antibiotic and steroid therapy. American Journal of Medicine 22, 872.CrossRefGoogle ScholarPubMed
Wickerham, L. J. (1957). Apparent increase in frequency of infections involving Torulopsis glabrata – procedure for its identification. Journal of the American Medical Association 165, 47.CrossRefGoogle ScholarPubMed